Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidoglycan biosynthesis enzymes are a group of bacterial proteins responsible for the stepwise construction of peptidoglycan, a critical component of the bacterial cell wall. Peptidoglycan provides structural strength, maintains cell shape, and protects bacteria from osmotic lysis. These enzymes catalyze reactions that assemble sugar and peptide subunits into a mesh-like polymer unique to bacteria. This process is essential for bacterial growth, division, and survival. Disruption leads to loss of cell wall integrity and ultimately cell lysis. Many antibiotics target these biosynthetic enzymes, exploiting differences between prokaryotic peptidoglycan synthesis machinery and eukaryotic cells.
Inhibition of peptidoglycan synthesis, leading to cell wall weakening and lysis
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidoglycan Biosynthesis Enzyme.